Author
E. P. Butlertanaka
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2021-2023 · peak 2/yrCo-Author Collaboration Network
10 top collaborators · 45 mutual co-author links6 papers
Recent·Most cited
- MicrobiologybioRxivPreprintDOI 10.1101/2023.10.14.562371
- MicrobiologybioRxivPreprint
Host ZCCHC3 blocks HIV-1 infection and production by a dual mechanism
B. Yi, Y. L. Tanaka, H. Kosako…·S. H. Yoshimura
This study identifies ZCCHC3 as a novel anti-HIV-1 factor that acts through a dual mechanism to block viral infection and production.
DOI 10.1101/2023.06.14.544911 - MicrobiologybioRxiv
SARS-CoV-2 spike S375F mutation characterizes the Omicron BA.1 variant
I. Kimura, D. Yamasoba, H. Nasser…·K. Sato
This study identifies the S375F mutation in the Omicron spike protein as responsible for its reduced cleavage efficiency, fusogenicity, and rapid spread.
DOI 10.1016/j.isci.2022.105720 - MicrobiologybioRxiv
Virological characteristics of SARS-CoV-2 BA.2 variant
D. Yamasoba, I. Kimura, H. Nasser…·Sawa
This study compares the virological characteristics of SARS-CoV-2 BA.2 and BA.1 variants, finding BA.2 has higher transmissibility, different antigenicity, greater replicative capacity, and higher pathogenicity in hamsters.
- MicrobiologybioRxiv
SARS-CoV-2 Lambda variant exhibits higher infectivity and immune resistance
I. Kimura, Y. Kosugi, J. Wu…·K. Sato
The paper investigates the SARS-CoV-2 Lambda variant, finding it more infectious due to specific mutations and better immune evasion, contributing to its spread in South America.
DOI 10.1016/j.celrep.2021.110218 - MicrobiologybioRxiv
SARS-CoV-2 spike P681R mutation, a hallmark of the Delta variant, enhances viral fusogenicity and pathogenicity
A. Saito, T. Irie, R. Suzuki…·K. Sato
This study shows the P681R mutation in the SARS-CoV-2 spike protein enhances fusogenicity and pathogenicity in the Delta variant compared to the prototypic virus.
DOI 10.1038/s41586-021-04266-9